Войдите в систему

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral and intravenous administration.

  1. Class I: Drugs with high solubility and high permeability, resulting in efficient absorption and minimal transporter influence (e.g., metoprolol, propranolol, and amoxicillin).
  2. Class II: Drugs with low solubility but high permeability, where efflux transporters can significantly limit absorption and pump drugs into bile (e.g., ezetimibe, ibuprofen, and ketoconazole).
  3. Class III: Drugs with high solubility but low permeability, where uptake transporters may enhance absorption (e.g., cimetidine, cephalexin, and ranitidine).
  4. Class IV: Drugs with low solubility and permeability. They often exhibit poor bioavailability due to dual limitations (e.g., itraconazole, chlorothiazide, and furosemide).

By integrating solubility and permeability, the Biopharmaceutical Classification System highlights how transporters influence drug disposition; for instance, Class II drugs face significant challenges due to efflux into the gastrointestinal lumen and biliary excretion.

Из главы 6:

article

Now Playing

6.25 : Hepatic Drug Clearance: Role of Transporters

Pharmacokinetics: Drug Excretion and Clearance

19 Просмотры

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

515 Просмотры

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

178 Просмотры

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

57 Просмотры

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

67 Просмотры

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

48 Просмотры

article

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

62 Просмотры

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

77 Просмотры

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

481 Просмотры

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

44 Просмотры

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

28 Просмотры

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

16 Просмотры

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

29 Просмотры

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

36 Просмотры

article

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

32 Просмотры

See More

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены